104 related articles for article (PubMed ID: 14696914)
1. Toxic pediatric parkinsonism: report of a child with metabolic studies and response to treatment.
Chutorian AM; Bojko A; Heier L; Frucht S; Nygaard T; Edelberg D
J Child Neurol; 2003 Nov; 18(11):812-5. PubMed ID: 14696914
[TBL] [Abstract][Full Text] [Related]
2. Parkinsonism induced by high-dose cytosine arabinoside.
Luque FA; Selhorst JB; Petruska P
Mov Disord; 1987; 2(3):219-22. PubMed ID: 3504550
[TBL] [Abstract][Full Text] [Related]
3. Parkinsonism associated with interferon alpha therapy for chronic myelogenous leukemia.
Sarasombath P; Sumida K; Kaku DA
Hawaii Med J; 2002 Mar; 61(3):48, 57. PubMed ID: 11965836
[TBL] [Abstract][Full Text] [Related]
4. Cytosine arabinoside and amphotericin B-induced parkinsonism.
Kulkantrakorn K; Selhorst JB; Petruska PJ
Ann Neurol; 1996 Mar; 39(3):413-4. PubMed ID: 8602767
[No Abstract] [Full Text] [Related]
5. Hydrocephalic parkinsonism due to Paget's disease of bone: dramatic improvement following ventriculoperitoneal shunt and temporary levodopa/carbidopa therapy.
Ikeda K; Kinoshita M; Aoki K; Tomatsuri A
Mov Disord; 1997 Mar; 12(2):241-2. PubMed ID: 9087985
[No Abstract] [Full Text] [Related]
6. Parkinsonism and bipolar affective disorder.
Northcott C; Lunn V; Yatham LN
Can J Psychiatry; 1995 Apr; 40(3):159-60. PubMed ID: 7606708
[No Abstract] [Full Text] [Related]
7. Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys: assessment with a new rating scale for monkey parkinsonism.
Kurlan R; Kim MH; Gash DM
Mov Disord; 1991; 6(2):111-8. PubMed ID: 2057003
[TBL] [Abstract][Full Text] [Related]
8. Parkinsonism from methanol poisoning: benefit from treatment with anti-Parkinson drugs.
Davis LE; Adair JC
Mov Disord; 1999 May; 14(3):520-2. PubMed ID: 10348484
[No Abstract] [Full Text] [Related]
9. [L-dopa with inhibitor in the treatment of parkinsonian syndrome-results of long-term observations].
Wasilewski R
Neurol Neurochir Pol; 1981; 15(4):411-6. PubMed ID: 7035990
[TBL] [Abstract][Full Text] [Related]
10. Clinical spectrum of secondary parkinsonism in childhood: a reversible disorder.
Pranzatelli MR; Mott SH; Pavlakis SG; Conry JA; Tate ED
Pediatr Neurol; 1994 Mar; 10(2):131-40. PubMed ID: 8024661
[TBL] [Abstract][Full Text] [Related]
11. Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia.
Shoulson I
Adv Neurol; 1983; 37():259-66. PubMed ID: 6134445
[No Abstract] [Full Text] [Related]
12. Reversible parkinsonism induced by prolonged treatment with valproate.
Onofrj M; Thomas A; Paci C
J Neurol; 1998 Dec; 245(12):794-6. PubMed ID: 9840351
[TBL] [Abstract][Full Text] [Related]
13. Sudden onset of confusion with severe exacerbation of parkinsonism during levodopa therapy.
Sage JI; Duvoisin RC
Mov Disord; 1986; 1(4):267-70. PubMed ID: 3504249
[TBL] [Abstract][Full Text] [Related]
14. Controlled-release carbidopa/levodopa (CR) in parkinsonian patients with response fluctuations on standard levodopa treatment: clinical and pharmacokinetic observations.
Deleu D; Jacques M; Michotte Y; Ebinger G
Neurology; 1989 Nov; 39(11 Suppl 2):88-92; discussion 95. PubMed ID: 2685654
[TBL] [Abstract][Full Text] [Related]
15. Parcopa: a rapidly dissolving formulation of carbidopa/levodopa.
Med Lett Drugs Ther; 2005 Jan; 47(1201):12. PubMed ID: 15706700
[TBL] [Abstract][Full Text] [Related]
16. Dopamine dysregulation syndrome and punding in levodopa-carbidopa intestinal gel (LCIG) infusion: A serious but preventable complication.
Salomone G; Marano M; di Biase L; Melgari JM; Di Lazzaro V
Parkinsonism Relat Disord; 2015 Sep; 21(9):1124-5. PubMed ID: 26242552
[No Abstract] [Full Text] [Related]
17. [Treatment of parkinsonism by L-dopa and dopa-decarboxylase inhibitor in a single tablet].
Sarova-Pinhas I; Braham J
Harefuah; 1974 Sep; 87(5):208-10. PubMed ID: 4435614
[No Abstract] [Full Text] [Related]
18. Unforeseen beneficial effects of controlled-release levodopa-carbidopa (Sinemet CR).
Makela EH; Cutlip WD
J Neuropsychiatry Clin Neurosci; 1992; 4(2):234-5. PubMed ID: 1627988
[No Abstract] [Full Text] [Related]
19. Case report: successful use of rectally administered levodopa-carbidopa.
Cooper SD; Ismail HA; Frank C
Can Fam Physician; 2001 Jan; 47():112-3. PubMed ID: 11212422
[No Abstract] [Full Text] [Related]
20. Carbidopa/levodopa extended-release capsules (Rytary).
Med Lett Drugs Ther; 2015 Apr; 57(1467):59-60. PubMed ID: 25897548
[No Abstract] [Full Text] [Related]
[Next] [New Search]
